html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

LARS2 - Perrault syndrome

This test is available for the following conditions:

Conditions > Metabolic disorders > Perrault syndrome

This product is also part of the following panels:

Comprehensive preconception carrier test panel¹
Disorders/differences of sex development (DSD) / Primary adrenal insufficiency panel
Hearing impairment panel (including GJB2)
Iron disorders panel
Liver disorders panel
Mendelian inherited disorders panel with genome wide CNV analysis
Mitochondrial disorders panel
Premature ovarian insufficiency panel

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method